Literature DB >> 25740666

Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.

K Zhang1, M Zhou, H Chen, G Wu, K Chen, H Yang.   

Abstract

PURPOSE: Giant cell tumor (GCT) of bone is a vessel-rich and infiltrative tumor, but the fundamental knowledge of its biological behavior remains unknown now.
METHODS: In this study, we evaluated the expression levels of Insulin-like growth factor 2 mRNA-binding protein 3 (IMP3), Insulin-like growth factor 2 (IGF2) and CD105 in 38 patients with GCT of spine by Immunohistochemical staining. Additionally, we also analyzed their correlations with clinicopathological factors of giant cell tumor of spine.
RESULTS: The results showed that positive expression of IMP3 and IGF2 was tightly related to the tumor extension and local recurrence of GCT (P < 0.05), but it did not indicate any association with patients' age, gender, tumor location and size. The mean microvessel densities (MVDs) of IMP3 and IGF2 were significantly higher in positive group than negative group (P < 0.05). Moreover, a significant correlation was found between IMP3 and IGF2 expression (r = 0.355, P = 0.029). The log-rank test revealed that local recurrence-free survival time was significantly shorter in the IMP3 positive group (P = 0.004), and the difference in the IGF2 positive group and negative group was also statistically significant (P = 0.008).
CONCLUSION: IMP3 and IGF2 might be potential biomarkers for GCT of spine in regulating the angiogenesis of giant cell tumor of bone and predicting the patients' prognosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740666     DOI: 10.1007/s12094-015-1280-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  30 in total

1.  Interferon alfa-2b for recurrent and metastatic giant cell tumor of the spine: report of two cases.

Authors:  Feng Wei; Xiaoguang Liu; Zhongjun Liu; Liang Jiang; Gengting Dang; Qingjun Ma; Lei Dang
Journal:  Spine (Phila Pa 1976)       Date:  2010-11-15       Impact factor: 3.468

2.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

3.  Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.

Authors:  Zhong Jiang; Peigou G Chu; Bruce A Woda; Kenneth L Rock; Qin Liu; Chung-Cheng Hsieh; Cuizhen Li; Wengang Chen; Hai Ou Duan; Scott McDougal; Chin-Lee Wu
Journal:  Lancet Oncol       Date:  2006-07       Impact factor: 41.316

4.  A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.

Authors:  J Nielsen; J Christiansen; J Lykke-Andersen; A H Johnsen; U M Wewer; F C Nielsen
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  Prognostic relevance of C-myc gene expression in giant-cell tumor of bone.

Authors:  G Gamberi; M S Benassi; T Böhling; P Ragazzini; L Molendini; M R Sollazzo; M Merli; C Ferrari; G Magagnoli; F Bertoni; P Picci
Journal:  J Orthop Res       Date:  1998-01       Impact factor: 3.494

6.  Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Authors:  F Tanaka; Y Otake; K Yanagihara; Y Kawano; R Miyahara; M Li; T Yamada; N Hanaoka; K Inui; H Wada
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

7.  Giant cell tumor of the mobile spine: a review of 49 cases.

Authors:  Stefano Boriani; Stefano Bandiera; Roberto Casadei; Luca Boriani; Rakesh Donthineni; Alessandro Gasbarrini; Elettra Pignotti; Roberto Biagini; Joseph H Schwab
Journal:  Spine (Phila Pa 1976)       Date:  2012-01-01       Impact factor: 3.468

8.  Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization.

Authors:  Zhou Ming; Chen Kangwu; Yang Huilin; Wang Genlin; Lu Jian; Ji Yiming; Wu Chunshen; Chen Chao
Journal:  Turk Neurosurg       Date:  2013       Impact factor: 1.003

9.  External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.

Authors:  Nathan E Hoffmann; Yuri Sheinin; Christine M Lohse; Alexander S Parker; Bradley C Leibovich; Zhong Jiang; Eugene D Kwon
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

10.  Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

Authors:  Ramaswamy Suvasini; Bhargava Shruti; Balaram Thota; Sridevi Vijay Shinde; Dinorah Friedmann-Morvinski; Zahid Nawaz; Krishnarao Venkatesh Prasanna; Kandavel Thennarasu; Alangar Sathyaranjandas Hegde; Arimappamagan Arivazhagan; Bangalore Ashwathnarayanarao Chandramouli; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

View more
  4 in total

1.  Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.

Authors:  Luyao Chen; Yongpeng Xie; Xintao Li; Liangyou Gu; Yu Gao; Lu Tang; Jianwen Chen; Xu Zhang
Journal:  Onco Targets Ther       Date:  2017-06-06       Impact factor: 4.147

2.  Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.

Authors:  Jiannan Liu; Ying Liu; Wenjing Gong; Xiangshuo Kong; Congcong Wang; Shuhua Wang; Aina Liu
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

3.  Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Min-Ying Su; Ning Lang
Journal:  J Bone Oncol       Date:  2021-03-16       Impact factor: 4.072

4.  EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma.

Authors:  Irene Dell'Anno; Marcella Barbarino; Elisa Barone; Antonio Giordano; Luca Luzzi; Maria Bottaro; Loredana Migliore; Silvia Agostini; Alessandra Melani; Ombretta Melaiu; Calogerina Catalano; Monica Cipollini; Roberto Silvestri; Alda Corrado; Federica Gemignani; Stefano Landi
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.